A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema-Reference-Cited by-同舟云学术

A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

Published:2005-10 Issue:10 Volume:112 Page:1747-1757
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Publisher

Elsevier BV

Subject

Ophthalmology

Reference27 articles.

1. The prevalence of diabetic retinopathy among adults in the United States;Arch Ophthalmol,2004

2. American Academy of Ophthalmology. Preferred practice pattern. Diabetic retinopathy. San Francisco: American Academy of Ophthalmology; 1998. Available at: http://www.aao.org/education/library/ppp/upload/Diabetic-Retinopathy.pdf. Accessed February 24, 2005.

3. The Wisconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years;Klein;Arch Ophthalmol,1984

4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;N Engl J Med,1993

5. UKPDS 50;Stratton;Diabetologia,2001

Cited by 521 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective Chapter: Translational implications of Proliferative Diabetic Retinopathy (PDR) vitreous fluid;Diabetic Retinopathy - Advancement in Understanding the Pathophysiology and Management Strategies [Working Title];2024-08-29

2. Global research trends and future directions in diabetic macular edema research: A bibliometric and visualized analysis;Medicine;2024-06-21

3. Intravitreal Injections of Bevacizumab (Avastin); which Dose is Recommended?;Khalij-Libya Journal of Dental and Medical Research;2024-06-04

4. Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease;Frontiers in Pharmacology;2024-05-24

5. Exploring the Therapeutic Potential of Anti-VEGF Drugs for the Management of Diabetic Retinopathy: An Overview;Current Diabetes Reviews;2024-04-16